Differential diagnosis of inflammatory bowel disease: imitations and complications

Gomollon, 2017, 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 1: diagnosis and medical management, J Crohns Colitis, 11, 3, 10.1093/ecco-jcc/jjw168 Magro, 2017, Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders, J Crohns Colitis, 11, 649, 10.1093/ecco-jcc/jjx008 Vermeire, 2006, Laboratory markers in IBD: useful, magic, or unnecessary toys?, Gut, 55, 426, 10.1136/gut.2005.069476 Annese, 2013, European evidence based consensus for endoscopy in inflammatory bowel disease, J Crohns Colitis, 7, 982, 10.1016/j.crohns.2013.09.016 Schumacher, 1994, A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation, Scand J Gastroenterol, 29, 318, 10.3109/00365529409094843 Geboes, 1998, Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease?, Am J Gastroenterol, 93, 201, 10.1111/j.1572-0241.1998.00201.x Weng, 2015, Seminar report from the 2014 Taiwan Society of Inflammatory Bowel Disease (TSIBD) spring forum (May 24th, 2014): Crohn's disease versus intestinal tuberculosis infection, Intest Res, 13, 6, 10.5217/ir.2015.13.1.6 Marshall, 1993, Tuberculosis of the gastrointestinal tract and peritoneum, Am J Gastroenterol, 88, 989 Makharia, 2007, Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis, Dig Dis Sci, 52, 33, 10.1007/s10620-006-9527-0 Kurti, 2015, Tuberculin skin test and quantiferon in BCG vaccinated, immunosuppressed patients with moderate-to-severe inflammatory bowel disease, J Gastrointestin Liver Dis, 24, 467, 10.15403/jgld.2014.1121.244.bcg Kim, 2011, Prospective evaluation of the clinical utility of interferon-gamma assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease, Inflamm Bowel Dis, 17, 1308, 10.1002/ibd.21490 Mao, 2015, Computed tomographic enterography adds value to colonoscopy in differentiating Crohn's disease from intestinal tuberculosis: a potential diagnostic algorithm, Endoscopy, 47, 322, 10.1055/s-0034-1391230 Lee, 2006, Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease, Endoscopy, 38, 592, 10.1055/s-2006-924996 Makharia, 2010, Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis, Am J Gastroenterol, 105, 642, 10.1038/ajg.2009.585 Almadi, 2009, Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge, Am J Gastroenterol, 104, 1003, 10.1038/ajg.2008.162 Boehme, 2010, Rapid molecular detection of tuberculosis and rifampin resistance, N Engl J Med, 363, 1005, 10.1056/NEJMoa0907847 Hillemann, 2011, Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system, J Clin Microbiol, 49, 1202, 10.1128/JCM.02268-10 Limsrivilai, 2017, Meta-analytic bayesian model for differentiating intestinal tuberculosis from Crohn's disease, Am J Gastroenterol, 112, 415, 10.1038/ajg.2016.529 Nahid, 2016, Executive summary: official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical practice guidelines: treatment of drug-susceptible tuberculosis, Clin Infect Dis, 63, 853, 10.1093/cid/ciw566 Rahier, 2014, Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease, J Crohns Colitis, 8, 443, 10.1016/j.crohns.2013.12.013 Dalby, 2017, Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study, BMC Microbiol, 17, 125, 10.1186/s12866-017-1035-1 Leirisalo-Repo, 1987, Yersinia arthritis. Acute clinical picture and long-term prognosis, Contrib Microbiol Immunol, 9, 145 Matsumoto, 1990, Endoscopic findings in Yersinia enterocolitica enterocolitis, Gastrointest Endosc, 36, 583, 10.1016/S0016-5107(90)71169-8 Ostroff, 1992, Clinical features of sporadic Yersinia enterocolitica infections in Norway, J Infect Dis, 166, 812, 10.1093/infdis/166.4.812 Cintron, 1996, Abdominal actinomycosis, Dis Colon Rectum, 39, 105, 10.1007/BF02048278 Wong, 2011, Actinomycosis, BMJ, 343, d6099, 10.1136/bmj.d6099 Hoentjen, 2012, Infectious proctitis: when to suspect it is not inflammatory bowel disease, Dig Dis Sci, 57, 269, 10.1007/s10620-011-1935-0 Vergidis, 2015, Histoplasmosis complicating tumor necrosis factor-alpha blocker therapy: a retrospective analysis of 98 cases, Clin Infect Dis, 61, 409, 10.1093/cid/civ299 Assi, 2007, Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients, Medicine (Baltimore), 86, 162, 10.1097/md.0b013e3180679130 Haque, 2003, Amebiasis, N Engl J Med, 348, 1565, 10.1056/NEJMra022710 Lee, 2015, Colonoscopic diagnosis of amebiasis: a case series and systematic review, Int J Colorectal Dis, 30, 31, 10.1007/s00384-014-2040-6 Qu, 2009, Strongyloides colitis is a lethal mimic of ulcerative colitis: the key morphologic differential diagnosis, Hum Pathol, 40, 572, 10.1016/j.humpath.2008.10.008 Ghosh, 2007, Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three cases, Trans R Soc Trop Med Hyg, 101, 1163, 10.1016/j.trstmh.2007.05.021 Brandt, 2015, ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI), Am J Gastroenterol, 110, 18, 10.1038/ajg.2014.395 Trotter, 2016, Ischaemic colitis, BMJ, 355, i6600, 10.1136/bmj.i6600 Montoro, 2011, Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study), Scand J Gastroenterol, 46, 236, 10.3109/00365521.2010.525794 Zuckerman, 2003, The colon single-stripe sign and its relationship to ischemic colitis, Am J Gastroenterol, 98, 2018, 10.1111/j.1572-0241.2003.07633.x Mitsudo, 1992, Pathology of intestinal ischemia, Surg Clin North Am, 72, 43, 10.1016/S0039-6109(16)45627-6 Jennette, 2013, 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides, Arthritis Rheum, 65, 1, 10.1002/art.37715 Sy, 2016, Vasculitis in patients with inflammatory bowel diseases: a study of 32 patients and systematic review of the literature, Semin Arthritis Rheum, 45, 475, 10.1016/j.semarthrit.2015.07.006 Mizuki, 1997, Pathogenic gene responsible for the predisposition of Behcet's disease, Int Rev Immunol, 14, 33, 10.3109/08830189709116843 1990, Criteria for diagnosis of Behcet's disease, Lancet, 335, 1078 Sakane, 1999, Behcet's disease, N Engl J Med, 341, 1284, 10.1056/NEJM199910213411707 Bjarnason, 1993, Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans, Gastroenterology, 104, 1832, 10.1016/0016-5085(93)90667-2 Lang, 1988, Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs, J Clin Pathol, 41, 516, 10.1136/jcp.41.5.516 Marlicz, 2014, Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine, Mayo Clin Proc, 89, 1699, 10.1016/j.mayocp.2014.07.015 Calmet, 2015, Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation, Ann Gastroenterol, 28, 366 Selbst, 2009, Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil, Mod Pathol, 22, 737, 10.1038/modpathol.2009.44 Hodi, 2010, Improved survival with ipilimumab in patients with metastatic melanoma, N Engl J Med, 363, 711, 10.1056/NEJMoa1003466 Beck, 2006, Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4, J Clin Oncol, 24, 2283, 10.1200/JCO.2005.04.5716 Gupta, 2015, Systematic review: colitis associated with anti-CTLA-4 therapy, Aliment Pharmacol Ther, 42, 406, 10.1111/apt.13281 Marthey, 2016, Cancer immunotherapy with anti-CTLA-4 monoclonal antibodies induces an inflammatory bowel disease, J Crohns Colitis, 10, 395, 10.1093/ecco-jcc/jjv227 Bergqvist, 2017, Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis, Cancer Immunol Immunother, 66, 581, 10.1007/s00262-017-1962-6 Carbonnel, 2017, Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?, Semin Immunopathol, 39, 327, 10.1007/s00281-016-0613-x Levine, 2014, ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents, J Pediatr Gastroenterol Nutr, 58, 795, 10.1097/MPG.0000000000000239 Blaydon, 2011, Inflammatory skin and bowel disease linked to ADAM17 deletion, N Engl J Med, 365, 1502, 10.1056/NEJMoa1100721 Cheng, 2009, Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome, Clin Immunol, 132, 124, 10.1016/j.clim.2009.03.514 Dhillon, 2014, Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease, Gastroenterology, 147, 680, 10.1053/j.gastro.2014.06.005 Meissner, 2010, Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease, Blood, 116, 1570, 10.1182/blood-2010-01-264218 Kato, 2011, Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection, Int J Hematol, 94, 479, 10.1007/s12185-011-0932-6 Uhlig, 2014, The diagnostic approach to monogenic very early onset inflammatory bowel disease, Gastroenterology, 147, 990, 10.1053/j.gastro.2014.07.023 Engelhardt, 2013, Clinical outcome in IL-10 and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation, J Allergy Clin Immunol, 131, 825, 10.1016/j.jaci.2012.09.025 Freeman, 2009, Relevance of segmental colitis with diverticulosis (SCAD) to other forms of inflammatory bowel disease, Can J Gastroenterol, 23, 439, 10.1155/2009/540420 Korelitz, 1984, Proctitis after fecal diversion in Crohn's disease and its elimination with reanastomosis: implications for surgical management. Report of four cases, Gastroenterology, 87, 710, 10.1016/0016-5085(84)90547-X Yantiss, 2006, Diagnostic difficulties in inflammatory bowel disease pathology, Histopathology, 48, 116, 10.1111/j.1365-2559.2005.02248.x Hasleton, 1985, Vascular changes in radiation bowel disease, Histopathology, 9, 517, 10.1111/j.1365-2559.1985.tb02833.x Hanson, 2012, Endoscopic and medical therapy for chronic radiation proctopathy: a systematic review, Dis Colon Rectum, 55, 1081, 10.1097/DCR.0b013e3182587aef Ananthakrishnan, 2011, Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease, Inflamm Bowel Dis, 17, 976, 10.1002/ibd.21457 Johnson, 2009, Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes, J Infect, 58, 403, 10.1016/j.jinf.2009.03.010 Ben-Horin, 2010, Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection, J Crohns Colitis, 4, 194, 10.1016/j.crohns.2009.11.001 Allegretti, 2017, The current landscape and lessons from fecal microbiota transplantation for inflammatory bowel disease: past, present, and future, Inflamm Bowel Dis, 23, 1710, 10.1097/MIB.0000000000001247 Kandiel, 2006, Cytomegalovirus colitis complicating inflammatory bowel disease, Am J Gastroenterol, 101, 2857, 10.1111/j.1572-0241.2006.00869.x Siegmund, 2017, Cytomegalovirus infection associated with inflammatory bowel disease, Lancet Gastroenterol Hepatol, 2, 369, 10.1016/S2468-1253(16)30159-5 Schwartz, 2002, The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota, Gastroenterology, 122, 875, 10.1053/gast.2002.32362 Parks, 1961, Pathogenesis and treatment of fistula-in-ano, BMJ, 1, 463, 10.1136/bmj.1.5224.463 Hamalainen, 1998, Incidence of fistulas after drainage of acute anorectal abscesses, Dis Colon Rectum, 41, 1357, 10.1007/BF02237048 Siegmund, 2016, Results of the fifth scientific workshop of the ECCO (II): pathophysiology of perianal fistulizing disease, J Crohns Colitis, 10, 377, 10.1093/ecco-jcc/jjv228 Soltani, 2010, Endorectal advancement flap for cryptoglandular or Crohn's fistula-in-ano, Dis Colon Rectum, 53, 486, 10.1007/DCR.0b013e3181ce8b01 Gecse, 2016, Results of the fifth scientific workshop of the ECCO [II]: clinical aspects of perianal fistulising Crohn's disease—the unmet needs, J Crohns Colitis, 10, 758, 10.1093/ecco-jcc/jjw039 Panes, 2017, Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy, Nat Rev Gastroenterol Hepatol, 14, 652, 10.1038/nrgastro.2017.104 Kotze, 2018, Modern management of perianal fistulas in Crohn's disease: future directions, Gut, 67, 1181, 10.1136/gutjnl-2017-314918 van der Zee, 2010, Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study, Br J Dermatol, 162, 195, 10.1111/j.1365-2133.2009.09430.x Kimball, 2016, Two phase 3 trials of adalimumab for hidradenitis suppurativa, N Engl J Med, 375, 422, 10.1056/NEJMoa1504370